MYUNGMOON Pharm co.,Ltd (KRX: 017180)

MYUNGMOON Pharm co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	68,228	76,621	97,023	159,901	245,768	118,913
Market Cap Growth	-19.81%	-21.03%	-39.32%	-34.94%	106.68%	-6.07%
Enterprise Value	154,570	159,448	175,770	244,712	325,526	225,080
Last Close Price	2035.00	2285.00	2870.00	4730.00	7270.00	4749.23
PE Ratio	-	-17.01	12.33	-23.29	-7.70	-5.68
PS Ratio	0.38	0.45	0.64	1.16	1.92	0.80
PB Ratio	0.85	0.86	1.02	1.86	2.71	1.48
P/FCF Ratio	-17.46	-9.39	25.91	332.93	-13.16	-7.98
P/OCF Ratio	-24.57	-14.79	17.72	187.02	-14.74	-40.44
EV/Sales Ratio	0.88	0.94	1.16	1.78	2.55	1.51
EV/EBITDA Ratio	1088.15	31.07	16.47	-145.85	-13.15	-21.16
EV/EBIT Ratio	-38.30	165.44	27.32	-41.61	-11.24	-15.74
EV/FCF Ratio	-40.48	-19.53	46.95	509.51	-17.43	-15.10
Debt / Equity Ratio	1.09	1.02	0.87	0.98	1.09	1.47
Debt / EBITDA Ratio	661.00	17.63	7.79	-	-	-
Debt / FCF Ratio	-24.39	-11.08	22.21	175.17	-5.29	-7.89
Asset Turnover	0.74	0.73	0.67	0.59	0.50	0.59
Inventory Turnover	2.48	2.67	2.88	2.70	2.94	3.66
Quick Ratio	0.58	0.42	0.39	0.36	0.38	0.54
Current Ratio	0.93	0.70	0.64	0.60	0.64	0.76
Return on Equity (ROE)	-9.09%	-5.30%	8.81%	-7.70%	-32.47%	-24.05%
Return on Assets (ROA)	-1.05%	0.26%	1.77%	-1.58%	-7.13%	-3.52%
Return on Capital (ROIC)	-1.38%	0.34%	2.31%	-2.04%	-9.34%	-4.56%
Earnings Yield	-11.39%	-5.91%	8.11%	-4.29%	-11.25%	-17.16%
FCF Yield	-5.60%	-10.65%	3.86%	0.30%	-7.60%	-12.54%
Buyback Yield / Dilution	2.20%	0.37%	-	-15.48%	-20.01%	-
Total Shareholder Return	2.20%	0.37%	-	-15.48%	-20.01%	-

Source: S&P Capital IQ. Standard template. Financial Sources.